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The magnitude of the adrenal cortical responses to artificial and natural stresses may be compared. The maximum plasma 1 -OHCS levels achieved with insulin hypoglycwmia, lysine-vasopressin and artificial fever are in the range 15-45 ,ug/100 ml. The levels found in patients with severe acute medical illnesses were higher, with a mean of about 50 gug/100 ml. An attempt can be made to translate these figures into cortisol secretion rates. We have figures for 78 simultaneous estimations of plasma 11-OHCS and cortisol secretion rates. The correlation coefficient is +0-783 with a regression equation SR=3 92 xplasma 11-OHCS -8. The response to the artificial stresses would approximate therefore to secretion rates of 50-150 mg/24 h although this rate would only be achieved for a short time. In acute medical illness, the mean plasma 1 1-OHCS level suggests a secretion rate of about 200 mg/24 h. This level of adrenal cortical activity might well continue for several days, although when plasma 1 1-OHCS levels were very high one would suspect an altered relationship to the secretion rate because of impairment of hepatic cortisol metabolism. It is common knowledge that an abundant food supply and obesity go hand in hand with a high incidence of diabetes mellitus. Conversely, low caloric intake and underweight is associated with a low or even absent diabetes morbidity. Recently hyperinsulinism has been recognized as accompanying excess weight and preceding hyperglycxemia and manifestations of spontaneous diabetes mellitus in both animals and men.
In man hyperinsulinism in obesity has been established by determining plasma insulin levels 'Supported by Deutsche Forschungsgemeinschaft, Bad Godesberg by bioand immuno-assay, in the fasting state and following stimulation of insulin secretion. However, a number of discrepancies exist between biologically and immunologically determined plasma insulin. On the basis of measurements of insulin-like-activity (ILA) and immunologically measurable insulin (IMI) both on natural and synthetic insulin, on isolated and combined A and B chains, on insulin secreted by pancreatic tissue in vitro, and in the Houssay preparation (dogs) as well as in the serum from normal, nondiabetic obese subjects and potential, latent and overt diabetic subjects, some obese and some non-obese, the following conclusions were drawn: ILA in serum, as measured by the rat fat pad technique, is composed of (1) pancreatic insulin that can be measured by immunoassay solely, and (2) a truly "insulin-like' fraction that survives pancreatectomy practically indefinitely (Schoffling 1966) . This latter fraction might be of extrapancreatic, perhaps hepatic, origin. Its level does not fluctuate following any. known stimulus or suppressant of insulin secretion. Part of it is extractable from defatted serum albumin. It shows clear-cut insulin-antagonistic properties in vitro despite its glyco-and lipo-genetic activity (Ditschuneit 1967) . ILA inhibited by antibodies in vitro ('suppressible' or 'typical' or 'free' insulin) cannot be identified with the insulin measured by radioimmunoassay. IMI disappears instantly after pancreatectomy and, therefore, reflects the pancreatic insulin proper.
Obesity, and only obesity, is associated with hyperinsulinism of literally pancreatic origin. This is inferred from elevated fasting levels of IMI established in this condition which increased rapidly and excessively following a variety of stimuli of insulin secretion applied by both oral and parenteral routes. On the other hand, in obesity ILA was also increased in the fasting state, but did not show marked differences from the ILA of the controls following glucose injection (Pfeiffer 1969) . Evaluation of the percentage increment of IMI and ILA above basal levels following stimulation was helpful in establishing this distinction. The insulin-antagonistic properties of a particular ILA fraction might depend on some 'buffering' function of this factor on the hyperreactive hyperinsulinism found in obesity. In obesity normal glucose assimilation is seen in spite of exaggerated insulin responses, which virtually implies peripheral insulin antagonism.
In contrast to obesity, in overt maturity-onset diabetes, we see decreased and delayed low IMI responses to glucose, implying impaired dynamics of insulin secretion. In the majority of cases fasting IMI is also subnormal, which reflects diminished pancreatic insulin production. This same defect also becomes obvious when the diabetic is subjected to repetitive stimulation of pancreatic insulin secretion by sulphonylureas, growth hormone and glucose infusions. The impaired P-cell function in maturity-onset diabetes ('incomplete p-cell insufficiency') has likewise already been established by ILA measurements (Pfeiffer et al. 1960 (Pfeiffer et al. , 1961 . It seems reasonable to assume that this parallelism is caused by reduction of the pancreatic part of ILA. Apparently neither the ILA of extrapancreatic origin nor the insulinantagonistic factor inherent in this fraction is elevated in elderly diabetics.
If obesity is combined with diabetes, opposite influences on the actual plasma IMI and ILA values are effective in both the fasting and the responsive states. Again, calculation of the individual insulin concentrations as percentage change from the basal insulin level reveals a reduced response not attributable to obesity.
Delayed and low insulin responses to glucose are found in obese as well as in thin diabetics. Absolute insulin values might sometimes give the impression that hyperinsulinism is present in obese diabetics. However, very moderate stimulators of insulin secretion such as the injection of small amounts of glucose intravenously can establish the impairment of insulin responses; often practically no response is seen in obese diabetic subjects. The different and variable states of ,-cell reserve and responsiveness in the individual case might explain apparently contradictory results in maturity-onset, and frequently obese, diabetics.
The problem still unsolved is that ofprediabetes or potential diabetes. Earlier studies on ILA in mothers of large babies with and without diabetic heredity revealed elevated fasting levels but nearly normal ILA responses following glucose stimulation, i.e. the ILA responses seen also in the obese subjects. Most of these female subjects, however, were markedly overweight. The most recent studies on IMI in 'true' prediabetics suggested low insulin responses to glucose in nondiabetic monozygotic twins of diabetics (Cerasi & Luft 1967) . On the other hand Melani (1968) , after extensive studies on IMI responses to small amounts of glucose, or tolbutamide and glucagon, administered intravenously in normal and obese, and in potential, latent and overt diabetic subjects, with or without associated obesity, found perfectly normal responses in potential diabetics of normal weight, but impaired reactions in nonobese latent and early diabetics. If potential, latent or early diabetes was combined with obesity, again the exaggerated insulin responses were seen. However, overt diabetics of long standing, whether of normal weight or obese, showed low insulin responses, as described before.
Thus, time will show whether or not low insulin responses to glucose, particularly early after the glucose, characterize the diabetic predisposition. So far, it appears that hyperreactive hyperinsulinism is connected with obesity rather than with one of these earlier periods in the natural history of diabetes.
